Detalhe da pesquisa
1.
Elevated alkaline phosphatase independently predicts early postoperative complications in noninfectious revision total shoulder arthroplasty.
Eur J Orthop Surg Traumatol
; 34(4): 2081-2087, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38532125
2.
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.
Oncologist
; 28(4): 341-350, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763374
3.
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
N Engl J Med
; 382(20): 1894-1905, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32402160
4.
Biology of IDH mutant cholangiocarcinoma.
Hepatology
; 75(5): 1322-1337, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35226770
5.
Bayesian Calibration of Computational Knee Models to Estimate Subject-Specific Ligament Properties, Tibiofemoral Kinematics, and Anterior Cruciate Ligament Force With Uncertainty Quantification.
J Biomech Eng
; 145(7)2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36826392
6.
Shoulder arthroplasty device clearance: an ancestral network analysis.
J Shoulder Elbow Surg
; 32(3): 671-676, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36279987
7.
Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma.
Gut
; 71(1): 185-193, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431577
8.
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(8): 995-1008, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798016
9.
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma.
J Hepatol
; 76(4): 862-873, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902530
10.
Biliary tract cancer.
Lancet
; 397(10272): 428-444, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516341
11.
Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2.
Oncologist
; 27(12): e938-e948, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190331
12.
Evolution of Systemic Therapy for Hepatocellular Carcinoma.
Hepatology
; 73 Suppl 1: 150-157, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380571
13.
Laboratory parameters and outcomes in hospitalized adults with COVID-19: a scoping review.
Infection
; 50(1): 1-9, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34247320
14.
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(7): 991-1001, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051880
15.
Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.
Cancer
; 127(6): 865-874, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231873
16.
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.
Br J Cancer
; 124(8): 1388-1397, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531690
17.
Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma.
Hepatology
; 71(4): 1247-1261, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31378984
18.
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab.
Liver Int
; 41(3): 598-607, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188713
19.
Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology.
Liver Int
; 41(11): 2759-2767, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173317
20.
Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α-fetoprotein: Outcomes by treatment-emergent ascites.
Hepatol Res
; 51(6): 715-721, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743189